Clinical Trial Results

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Pulmonary Hypertension Association Registry

N/AOBSERVATIONAL Phoenix, Arizona +4 more

RECRUITING

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

N/AOBSERVATIONAL Phoenix, Arizona +4 more

RECRUITING

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

PHASE2INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

Repurposing Valsartan May Protect Against Pulmonary Hypertension

PHASE2INTERVENTIONAL Seattle, Washington

RECRUITING

Global Paradise System US Post Approval Study

N/AOBSERVATIONAL Long Beach, California +4 more

RECRUITING

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

PHASE3INTERVENTIONAL Fairhope, Alabama +4 more

RECRUITING

PAH Exercise Study

PHASE3INTERVENTIONAL Seattle, Washington

RECRUITING

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

PHASE3INTERVENTIONAL Alexander City, Alabama +4 more

RECRUITING

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

N/AOBSERVATIONAL Palo Alto, California +4 more

RECRUITING

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING